These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22350803)

  • 1. Sotalol permeability in cultured-cell, rat intestine, and PAMPA system.
    Liu W; Okochi H; Benet LZ; Zhai SD
    Pharm Res; 2012 Jul; 29(7):1768-74. PubMed ID: 22350803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pH Dependent but not P-gp Dependent Bidirectional Transport Study of S-propranolol: The Importance of Passive Diffusion.
    Zheng Y; Benet LZ; Okochi H; Chen X
    Pharm Res; 2015 Aug; 32(8):2516-26. PubMed ID: 25690341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the Utility of Canine Mdr1 Knockout Madin-Darby Canine Kidney I Cells in Permeability Screening and Efflux Substrate Determination.
    Chen EC; Broccatelli F; Plise E; Chen B; Liu L; Cheong J; Zhang S; Jorski J; Gaffney K; Umemoto KK; Salphati L
    Mol Pharm; 2018 Nov; 15(11):5103-5113. PubMed ID: 30222362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic characterization of anhuienoside C and its deglycosylated metabolites in rats.
    Sun H; Liu H; Zhao H; Wang Y; Li YL; Ye WC; Wu B
    Xenobiotica; 2017 Oct; 47(10):885-893. PubMed ID: 27662115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-permeability criterion for BCS classification: segmental/pH dependent permeability considerations.
    Dahan A; Miller JM; Hilfinger JM; Yamashita S; Yu LX; Lennernäs H; Amidon GL
    Mol Pharm; 2010 Oct; 7(5):1827-34. PubMed ID: 20701326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of an acyloxyalkoxy-based cyclic prodrug of the opioid peptide DADLE.
    Tang F; Borchardt RT
    Pharm Res; 2002 Jun; 19(6):780-6. PubMed ID: 12134947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of MDCK-MDR1 and Caco-2 cell based permeability assays for anti-malarial drug screening and drug investigations.
    Jin X; Luong TL; Reese N; Gaona H; Collazo-Velez V; Vuong C; Potter B; Sousa JC; Olmeda R; Li Q; Xie L; Zhang J; Zhang P; Reichard G; Melendez V; Marcsisin SR; Pybus BS
    J Pharmacol Toxicol Methods; 2014; 70(2):188-94. PubMed ID: 25150934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of the coumarinic acid-based cyclic prodrug of the opioid peptide DADLE.
    Tang F; Borchardt RT
    Pharm Res; 2002 Jun; 19(6):787-93. PubMed ID: 12134948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of MDCK cells with low expression of
    Bokulić A; Padovan J; Stupin-Polančec D; Milić A
    Acta Pharm; 2022 Jun; 72(2):275-288. PubMed ID: 36651516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and Validation of Canine P-Glycoprotein-Deficient MDCK II Cell Lines for Efflux Substrate Screening.
    Ye D; Harder A; Fang Z; Weinheimer M; Laplanche L; Mezler M
    Pharm Res; 2020 Sep; 37(10):194. PubMed ID: 32918191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using in vitro ADME data for lead compound selection: An emphasis on PAMPA pH 5 permeability and oral bioavailability.
    Williams J; Siramshetty V; Nguyễn ÐT; Padilha EC; Kabir M; Yu KR; Wang AQ; Zhao T; Itkin M; Shinn P; Mathé EA; Xu X; Shah P
    Bioorg Med Chem; 2022 Feb; 56():116588. PubMed ID: 35030421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal Permeability of β-Lapachone and Its Cyclodextrin Complexes and Physical Mixtures.
    Mangas-Sanjuan V; Gutiérrez-Nieto J; Echezarreta-López M; González-Álvarez I; González-Álvarez M; Casabó VG; Bermejo M; Landin M
    Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):795-806. PubMed ID: 26602766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are MDCK cells transfected with the human MDR1 gene a good model of the human intestinal mucosa?
    Tang F; Horie K; Borchardt RT
    Pharm Res; 2002 Jun; 19(6):765-72. PubMed ID: 12134945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfected MDCK cell line with enhanced expression of CYP3A4 and P-glycoprotein as a model to study their role in drug transport and metabolism.
    Kwatra D; Budda B; Vadlapudi AD; Vadlapatla RK; Pal D; Mitra AK
    Mol Pharm; 2012 Jul; 9(7):1877-86. PubMed ID: 22676443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of MDR1-overexpressing cell lines to derive a quantitative prediction approach for brain disposition using in vitro efflux activities.
    Sato S; Tohyama K; Kosugi Y
    Eur J Pharm Sci; 2020 Jan; 142():105119. PubMed ID: 31682973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of sodium-dependent multivitamin transporter in MDCK-MDR1 cells and its utilization as a target for drug delivery.
    Luo S; Kansara VS; Zhu X; Mandava NK; Pal D; Mitra AK
    Mol Pharm; 2006; 3(3):329-39. PubMed ID: 16749865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of intestinal absorption of ginsenoside Rg1 incorporated in microemulison using parallel artificial membrane permeability assay.
    Han M; Fu S; Gao JQ; Fang XL
    Biol Pharm Bull; 2009 Jun; 32(6):1069-74. PubMed ID: 19483317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advances in the MDCK-MDR1 cell model and its applications to screen drug permeability].
    Liu Y; Zeng S
    Yao Xue Xue Bao; 2008 Jun; 43(6):559-64. PubMed ID: 18822955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanding the Efflux In Vitro Assay Toolbox: A CRISPR-Cas9 Edited MDCK Cell Line with Human BCRP and Completely Lacking Canine MDR1.
    Wegler C; Gazit M; Issa K; Subramaniam S; Artursson P; Karlgren M
    J Pharm Sci; 2021 Jan; 110(1):388-396. PubMed ID: 33007277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the expression of endogenous efflux transporters in MDR1-transfected versus wildtype cell lines affect P-glycoprotein mediated drug transport.
    Kuteykin-Teplyakov K; Luna-Tortós C; Ambroziak K; Löscher W
    Br J Pharmacol; 2010 Jul; 160(6):1453-63. PubMed ID: 20590635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.